Neumora Therapeutics, Inc.
NMRA- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001885522
In the last 90 days, Neumora Therapeutics, Inc. insiders filed 0 open-market purchases and 2 sales; 113 institutions reported holding it in 13F filings for Q2 2026, worth $129.2M in total; no superinvestor holds it.
Q2 2024 vs. Q1 2024
How the institutions holding Neumora Therapeutics, Inc. changed between Q1 2024 and Q2 2024.
All holders in Q2 2024All holders in Q1 2024
| Measure | Q1 2024 | Q2 2024 | Change |
|---|---|---|---|
| Holders | 88 | 93 | +5 |
| Shares | 52.7M | 63.8M | +11.1M (+21.1%) |
| Value | $725.4M | $627.4M | −$98.0M (−13.5%) |
New holders (24)
Institutions that held Neumora Therapeutics, Inc. at the end of Q2 2024 but not at the end of Q1 2024.
Sold out (19)
Institutions that held Neumora Therapeutics, Inc. at the end of Q1 2024 and filed for Q2 2024 without it.
| Institution | Shares, Q1 2024 | Value, Q1 2024 |
|---|---|---|
| Deep Track Capital, LP | 1,000,000 | $13.8M |
| Pier Capital, LLC | 249,336 | $3.43M |
| LMR Partners LLP | 187,811 | $2.58M |
| Renaissance Technologies LLC | 138,900 | $1.91M |
| Millennium Management LLC | 136,526 | $1.88M |
| Auour Investments LLC | 105,087 | $1.44M |
| Hudson Bay Capital Management LP | 98,300 | $1.35M |
| BIT Capital GmbH | 91,656 | $1.26M |
| Nan Fung Group Holdings Ltd | 63,315 | $870.6K |
| Wildcat Capital Management, LLC | 54,894 | $754.8K |
| Gsa Capital Partners LLP | 29,821 | $410.0K |
| Qube Research & Technologies Ltd | 18,242 | $250.8K |
| Wellington Management Group LLP | 14,187 | $195.1K |
| Wealth Enhancement Advisory Services, LLC | 12,576 | $172.9K |
| XTX Topco Ltd | 12,352 | $169.8K |
| Oxford Asset Management LLP | 10,000 | $137.5K |
| American International Group, Inc. | 7,331 | $100.8K |
| Metropolitan Life Insurance Co | 921 | $12.7K |
| The PNC Financial Services Group, Inc. | 5 | $69 |